InMode Ltd.

NASDAQ:INMD

Medical - Devices

Healthcare
$12.88 +0.26%

+$0.04 today

Market cap
$741.17M
Beta
1.93
P/E (TTM)
9.7
EPS (TTM)
$1.38
52W Low $12.72High $16.74

Volume 0.31M

Average 0.85M

INMD Research & Development

Spending on developing new products, technologies, and improvements to existing offerings.

InMode Ltd.NASDAQ: INMD

Research & Development · Q1 FY2026 · quarter ended Mar 2026

Research & development growth accelerates

Q1 FY2026 research & development of $3.54M rose 22.3% year over year, ahead of the +11.6% change in trailing-twelve-month research & development. Sequentially, it rose 0.9% from the prior quarter. Over 3 fiscal years it compounded at +2.3% a year.

Context

  • Research & development amounted to 3.6% of revenue in FY2025, up 0.3 pp from a year earlier.
  • Research & development increased in 2 of the last 3 fiscal years.

What to watch

Whether quarterly growth of +22.3% holds above the trailing-twelve-month pace of +11.6%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$3.54M+0.9% QoQ
Last fiscal yearDec 2025
$13.32M+1.4% YoY
LTMMar 2026
$13.97M+11.6% YoY
Research & Development past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+22.3%——
1 year+1.4%——
3-year CAGR+2.3%——
5-year CAGR——
10-year CAGR——

Research & Development history

USD · from the income statement

Latest · FY2025
13.32M USD
Year-over-year change
+1.4%
4-year CAGR
+8.7%

Research & Development vs competitors

How INMD compares with its peers on the latest reported figures

  • INMD's LTM Mar 2026 research & development of $13.97M is the 3rd highest of the 5 companies compared; the peer median is $12.91M.
  • Its year-over-year change of +11.6% is the 2nd highest of 4, against a peer median of +0.9%.
  • Research & development amounts to 3.7% of revenue for INMD, versus a peer median of 4.8%.
INMD Competitors Peer median
Research & Development for INMD and competitors
Company Period LTM YoY 3-year CAGR% of revenue
ALGNAlign Technology, Inc.LTM Jun 2026$377M +0.9%+6.6%9.1%
ESTAEstablishment Labs Holdings Inc.LTM Sep 2026$20.08M +0.6%-0.0%7.6%
INMDInMode Ltd.LTM Mar 2026$13.97M +11.6%+2.3%3.7%
SKINThe Beauty Health CompanyLTM Mar 2026$5.73M +27.7%-12.6%1.9%
AIRSAirSculpt Technologies, Inc.LTM Mar 2026$0 ——0.0%
Peer median (excluding INMD) $12.91M+0.9%-0.0%4.8%

Competitors are the stored peer set for INMD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue357.57M454.27M492.05M394.82M370.5M
Cost of Revenue53.59M73.49M80.71M77.75M79.53M
Gross Profit303.97M380.79M411.34M317.07M290.97M
Gross Margin85.0%83.8%83.6%80.3%78.5%
Research & Development9.53M12.43M13.41M13.14M13.32M
Selling, General & Admin127.76M170.51M202.27M191.4M192.26M
Operating Expenses136.5M182.93M215.68M204.54M205.58M
Depreciation & Amortization517K680K623K728K695K
EBITDA168.52M202.15M217.89M144.2M111.03M
EBITDA Margin47.1%44.5%44.3%36.5%30.0%
Operating Income167.48M197.85M195.66M112.53M85.39M
Operating Margin46.8%43.6%39.8%28.5%23.0%
Interest Income525K3.61M21.61M30.94M24.94M
Interest Expense00000
Other Income / Expenses525K3.61M21.61M30.94M24.94M
Income Before Tax168M201.47M217.27M143.47M110.33M
Pre-Tax Margin47.0%44.3%44.2%36.3%29.8%
Income Tax Expense2.93M39.95M19.35M(37.81M)16.5M
Net Income164.97M161.52M197.92M181.28M93.83M
Net Margin46.1%35.6%40.2%45.9%25.3%
EPS (Basic)2.031.962.372.291.45
EPS (Diluted)1.921.892.302.251.43
Weighted Avg Shares81.44M82.48M83.53M79.31M64.63M
Weighted Avg Shares (Diluted)86.02M85.4M85.95M80.6M65.44M

InMode Ltd.

NASDAQ:INMD

Intrinsic Alpha fair value

Locked

Current Price

$12.88

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.